Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cryoballoon ablation outcomes for paroxysmal atrial fibrillation

BACKGROUND: Cryoballoon ablation (CBA) is recommended for patients with paroxysmal atrial fibrillation (AF) refractory to antiarrhythmic drugs. However, only 80% of patients benefit from initial CBA. There is growing evidence that pretreatment with angiotensin-converting enzyme inhibitors (ACEIs) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Seykal, Ibragim, Bose, Abhishek, Chevli, Parag A, Hashmath, Zeba, Sharma, Nitish, Mishra, Ajay K, Laidlaw, Douglas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627355/
https://www.ncbi.nlm.nih.gov/pubmed/36339889
http://dx.doi.org/10.4330/wjc.v14.i10.537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627355/
https://www.ncbi.nlm.nih.gov/pubmed/36339889
http://dx.doi.org/10.4330/wjc.v14.i10.537

Ejemplares similares